{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:37:45Z","timestamp":1793090265506,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"R&D, Nycomed GmbH"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.lfs.2013.01.028","type":"journal-article","created":{"date-parts":[[2013,2,8]],"date-time":"2013-02-08T22:46:48Z","timestamp":1360363608000},"page":"708-718","source":"Crossref","is-referenced-by-count":172,"title":["Efficacy of drugs used in the treatment of IBD and combinations thereof in acute DSS-induced colitis in mice"],"prefix":"10.1016","volume":"92","author":[{"given":"Holger","family":"Sann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmin von","family":"Erichsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Hessmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Pahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Hoffmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2013.01.028_bb0005","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1046\/j.1365-2036.1998.00357.x","article-title":"Experimental colitis induced by dextran sulphate sodium in mice: beneficial effects of sulphasalazine and olsalazine","volume":"12","author":"Axelsson","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.lfs.2013.01.028_bb0010","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1023\/A:1015339018181","article-title":"Effect of cyclosporine in a murine model of experimental colitis","volume":"47","author":"Bani\u0107","year":"2002","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.lfs.2013.01.028_bb0015","first-page":"G685","article-title":"Role of serotonin in intestinal inflammation: knockout of serotonin reuptake transporter exacerbates 2,4,6-trinitrobenzene sulfonic acid colitis in mice","volume":"296","author":"Bischoff","year":"2009","journal-title":"Am J Physiol"},{"key":"10.1016\/j.lfs.2013.01.028_bb0020","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2036.2011.04905.x","article-title":"Review article: the benefits of pharmacogenetics for improving thiopurine therapy in inflammatory bowel disease","volume":"35","author":"Chouchana","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.lfs.2013.01.028_bb0025","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1136\/gutjnl-2011-300904","article-title":"New therapies for inflammatory bowel disease: from the bench to the bedside","volume":"61","author":"Danese","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.lfs.2013.01.028_bb0030","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1016\/S0002-9440(10)65087-0","article-title":"Dextran sulfate sodium-induced colonic histopathology, but not altered epithelial ion transport, is reduced by inhibition of phosphodiesterase activity","volume":"156","author":"Diaz-Granados","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.lfs.2013.01.028_bb0035","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.crohns.2009.12.002","article-title":"European Crohn's and Colitis Organisation (ECCO). The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: current management","volume":"4","author":"Dignass","year":"2010","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.lfs.2013.01.028_bb0040","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000007822","article-title":"Characterisation of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency","volume":"62","author":"Egger","year":"2000","journal-title":"Digestion"},{"key":"10.1016\/j.lfs.2013.01.028_bb0045","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.phrs.2008.08.006","article-title":"The application and relevance of ex vivo culture systems for assessment of IBD treatment in murine models of colitis","volume":"58","author":"Fritsch Fredin","year":"2008","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.lfs.2013.01.028_bb0050","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1021\/jm021062y","article-title":"Design and synthesis of dihydrofolate reductase inhibitors encompassing a bridging ester group. Evaluation in a mouse colitis model","volume":"46","author":"Graffner-Nordberg","year":"2003","journal-title":"J Med Chem"},{"key":"10.1016\/j.lfs.2013.01.028_bb0055","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.3109\/00365520903262414","article-title":"Oral administration of mesalazine protects against mucosal injury and permeation in dextran sulfate sodium-induced colitis in rats","volume":"44","author":"Hayashi","year":"2009","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.lfs.2013.01.028_bb0060","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1124\/jpet.106.111146","article-title":"The prevention of colitis by E Prostanoid receptor 4 agonist through enhancement of epithelium survival and regeneration","volume":"320","author":"Jiang","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.lfs.2013.01.028_bb0065","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1124\/jpet.110.173252","article-title":"Comparison of prostaglandin E2 receptor subtype 4 agonist and sulfasalazine in mouse colitis prevention and treatment","volume":"335","author":"Jiang","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.lfs.2013.01.028_bb0070","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1172\/JCI0214459","article-title":"The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut","volume":"109","author":"Kabashima","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.lfs.2013.01.028_bb0075","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1002\/ibd.21557","article-title":"Pharmacological intervention studies using mouse models of the inflammatory bowel diseases: translating preclinical data into new drug therapies","volume":"17","author":"Koboziev","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.lfs.2013.01.028_bb0080","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1365-2249.1997.291-ce1184.x","article-title":"Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice","volume":"107","author":"Kojouharoff","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.lfs.2013.01.028_bb0085","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1471-230X-11-47","article-title":"Safety and efficacy of the immunosuppressive agent 6-tioguanine in murine model of acute and chronic colitis","volume":"11","author":"Kverka","year":"2011","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.lfs.2013.01.028_bb0090","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/intimm\/dxh006","article-title":"Regulation of chronic colitis in athymic nu\/nu (nude) mice","volume":"16","author":"Laroux","year":"2004","journal-title":"Int Immunol"},{"key":"10.1016\/j.lfs.2013.01.028_bb0095","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1124\/jpet.103.051771","article-title":"Glucagon-like peptide-2 and common therapeutics in a murine model of ulcerative colitis","volume":"306","author":"L'Heureux","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.lfs.2013.01.028_bb0100","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1124\/jpet.102.039529","article-title":"The specific type-4 phosphodiesterase inhibitor mesopram alleviates experimental colitis in mice","volume":"305","author":"Loher","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.lfs.2013.01.028_bb0105","first-page":"G544","article-title":"Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis","volume":"274","author":"M\u00e4hler","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.lfs.2013.01.028_bb0110","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s10620-007-0133-6","article-title":"Suppression of ulcerative colitis in mice by orally available inhibitors of sphingosine kinase","volume":"53","author":"Maines","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.lfs.2013.01.028_bb0115","first-page":"G797","article-title":"Dextran sulfate sodium-induced murine colitis activates NF-kappaB and increases galanin-1 receptor expression","volume":"278","author":"Marrero","year":"2000","journal-title":"Am J Physiol"},{"key":"10.1016\/j.lfs.2013.01.028_bb0120","doi-asserted-by":"crossref","first-page":"5.58.1","DOI":"10.1002\/0471141755.ph0558s47","article-title":"Methods of inducing inflammatory bowel disease in mice","volume":"47","author":"Maxwell","year":"2009","journal-title":"Curr Protoc Pharmacol"},{"key":"10.1016\/j.lfs.2013.01.028_bb0125","first-page":"3204","article-title":"Current treatment of ulcerative colitis","volume":"17","author":"Meier","year":"2011","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.lfs.2013.01.028_bb0130","first-page":"G1328","article-title":"Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL\/6 but not in BALB\/c mice: correlation between symptoms and inflammation","volume":"288","author":"Melgar","year":"2005","journal-title":"Am J Physiol"},{"key":"10.1016\/j.lfs.2013.01.028_bb0135","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.intimp.2008.01.036","article-title":"Validation of murine dextran sulfate sodium-induced colitis using four therapeutic agents for human inflammatory bowel disease","volume":"8","author":"Melgar","year":"2008","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.lfs.2013.01.028_bb0140","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1007\/BF01303184","article-title":"Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin","volume":"38","author":"Murthy","year":"1993","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.lfs.2013.01.028_bb0145","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s000110050177","article-title":"The efficacy of BAY y 1015 in dextran sulfate model of mouse colitis","volume":"46","author":"Murthy","year":"1997","journal-title":"Inflamm Res"},{"key":"10.1016\/j.lfs.2013.01.028_bb0150","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/ibd.21080","article-title":"Effect of EP4 agonist (ONO-4819CD) for patients with mild to moderate ulcerative colitis refractory to 5-aminosalicylates: a randomized phase II, placebo-controlled trial","volume":"16","author":"Nakase","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.lfs.2013.01.028_bb0155","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1084\/jem.20090849","article-title":"TNF suppresses acute intestinal inflammation by inducing local glucocorticoid synthesis","volume":"207","author":"Noti","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.lfs.2013.01.028_bb0160","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/00005176-199511000-00007","article-title":"Antiserum to tumor necrosis factor and failure to prevent murine colitis","volume":"21","author":"Olson","year":"1995","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.lfs.2013.01.028_bb0165","doi-asserted-by":"crossref","first-page":"35605","DOI":"10.1074\/jbc.M205826200","article-title":"Cyclosporine A enhances leukocyte binding by human intestinal microvascular endothelial cells through inhibition of p38 MAPK and iNOS. Paradoxical proinflammatory effect on the microvascular endothelium","volume":"277","author":"Rafiee","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.lfs.2013.01.028_bb0170","first-page":"G514","article-title":"Cyclosporine regulates intestinal epithelial apoptosis via TGF-beta-related signaling","volume":"297","author":"Satoh","year":"2009","journal-title":"Am J Physiol"},{"key":"10.1016\/j.lfs.2013.01.028_bb0175","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/00054725-200411000-00014","article-title":"Effect of cyclosporin A on cell adhesion molecules and leukocyte-endothelial cell interactions in experimental colitis","volume":"10","author":"Soriano-Izquierdo","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.lfs.2013.01.028_bb0180","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1080\/003655200750023787","article-title":"The effect of dexamethasone treatment on murine colitis","volume":"35","author":"van Meeteren","year":"2000","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.lfs.2013.01.028_bb0185","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1023\/B:DDAS.0000026298.72088.f7","article-title":"Impact of dextran sulfate sodium load on the severity of inflammation in experimental colitis","volume":"49","author":"Vowinkel","year":"2004","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.lfs.2013.01.028_bb0190","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nprot.2007.41","article-title":"Chemically induced mouse models of intestinal inflammation","volume":"2","author":"Wirtz","year":"2007","journal-title":"Nat Protoc"},{"key":"10.1016\/j.lfs.2013.01.028_bb0195","doi-asserted-by":"crossref","first-page":"e6073","DOI":"10.1371\/journal.pone.0006073","article-title":"Temporal and spatial analysis of clinical and molecular parameters in dextran sodium sulfate induced colitis","volume":"4","author":"Yan","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2013.01.028_bb0200","doi-asserted-by":"crossref","DOI":"10.1007\/BF01996100","article-title":"Experimental colitis in mice: effects of olsalazine on eicosanoid production in colonic tissue","author":"Zijlstra","year":"1992","journal-title":"Agents Actions"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320513000684?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320513000684?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T03:08:16Z","timestamp":1595387296000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320513000684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0024320513000684"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2013.01.028","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}